Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-08-04FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Venlafaxine hydrochloride by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2010-06-28FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's venlafaxine hydrochloride as an Original Application generic (ANDA). The approval enables a generic version of venlafaxi…
-
FDA approval · 2010-06-27FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for clonazepam submitted by Teva Pharmaceuticals USA, Inc., marking an updated regulatory action for…
-
FDA approval · 2010-06-25FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for fluoxetine hydrochloride (fluoxetine) from QUALLENT PHARMACEUTICALS HEALTH LLC, updating the app…
-
FDA approval · 2010-06-21FDA Approved: PAROXETINE HYDROCHLORIDE — Original Application (Oxford Pharmaceuticals, LLC)
FDA approved Paroxetine hydrochloride as an Original Application (ANDA) generic for Oxford Pharmaceuticals, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-05-19FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for fluoxetine submitted by Teva Pharmaceuticals USA, Inc. (the snippet does not specify the exact c…
-
CLINICAL_TRIALS trial_result · 2010-05-18Clinical Trial Update: The Effects of Treatment With Sertraline for Noncardiac Chest Pain [Phase 4]
Phase 4 clinical trial evaluating sertraline for noncardiac chest pain has completed. The study involves patients with panic attacks and dep…
-
FDA approval · 2010-04-07FDA Approved: VENLAFAXINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for Venlafaxine hydrochloride, a generic version of venlafaxine.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder [Phase 3]
Phase 3 randomized trial comparing venlafaxine with paroxetine for panic disorder has completed.
-
FDA approval · 2010-03-25FDA Approved: PAROXETINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for paroxetine hydrochloride hemihydrate from Mylan Pharmaceuticals Inc., advancing the generic …
-
FDA approval · 2010-03-25FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for paroxetine hydrochloride from Apotex Corp., granting approval for an additional generic product.
-
FDA approval · 2010-03-22FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved a generic version of fluoxetine hydrochloride (an SSRI) from Dr. Reddy's Laboratories Limited under an Original Application (AN…
-
FDA approval · 2010-03-16FDA Approved: ALPRAZOLAM — Original Application (Actavis Pharma, Inc.)
FDA approves Actavis Pharma, Inc.'s generic alprazolam through an Original Application (ANDA).
-
FDA approval · 2010-03-15FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. under ANDA076690.
-
FDA approval · 2010-03-11FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application submitted by BluePoint Laboratories for venlafaxine (venlafaxine hydrochloride) as a generic product…
-
FDA approval · 2010-02-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited under an ANDA. This confirms reg…
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: Physical Exercise Versus Cognitive-behavioral Therapy (CBT) for Panic Disorders: A Randomised Controlled Trial [Phase 2]
A Phase 2 randomized controlled trial compared physical exercise to cognitive-behavioral therapy for Panic Disorder to evaluate relative eff…
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Cognitive Behavior Psychotherapy in Panic Disorder [NA]
A completed clinical trial evaluating cognitive-behavioral psychotherapy for panic disorder with agoraphobia. The study status is completed.
-
FDA approval · 2010-01-06FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2009-10-15FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for clonazepam filed by Teva Pharmaceuticals USA, Inc., indicating an update under the approved …
-
FDA approval · 2009-10-15FDA Approved: CLONAZEPAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a clonazepam generic product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder [Phase 4]
A Phase 4 trial compared adding Niravam (alprazolam) to an SSRI or SNRI versus SSRI or SNRI alone in generalized anxiety disorder or panic d…
-
FDA approval · 2009-09-30FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic venlafaxine product manufactured by Heritage Pharmaceuticals (d/b/a Avet Pharmaceutica…
-
FDA approval · 2009-09-28FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., updating the approval status of the drug. Th…
-
FDA approval · 2009-09-28FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved the supplemental application for sertraline hydrochloride from Granules Pharmaceuticals Inc., confirming regulatory approval of…